(Q52844823)

8 May 2018

title

HIV-1 neutralizing antibodies: how full is the bottle? (English)

1 reference

8 May 2018

1 reference

Moore JP

1

1 reference

8 May 2018

Burton DR

series ordinal

2

1 reference

8 May 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

8 May 2018

published in

Nature Medicine

1 reference

8 May 2018

volume

5

1 reference

8 May 2018

issue

2

1 reference

8 May 2018

page(s)

142-144

1 reference

8 May 2018

https://scigraph.springernature.com/pub.10.1038/5502

exact match

0 references

cites work

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

Why do we not have an HIV vaccine and how can we make one? .

21 January 2018

1 reference

Progress in the development of an HIV-1 vaccine

21 January 2018

1 reference

Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

21 January 2018

1 reference

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

21 January 2018

1 reference

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

21 January 2018

1 reference

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

21 January 2018

1 reference

Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccines

21 January 2018

1 reference

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

21 January 2018

1 reference

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group

21 January 2018

1 reference

Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/5502

1 reference

8 May 2018

1 reference

8 May 2018